ConductScience.org, home

Comparison · NCT04472377-7acb38a9

Self-collected Specimens vs Physician-sampled Specimens: Percentage of a Valid Specimen, According to the Presence of the Beta-globin Gene in Specimens

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Self-collected Specimens vs Physician-sampled Specimens: Percentage of a Valid Specimen, According to the Presence of the Beta-globin Gene in Specimens. Trial comparisons, record NCT04472377-7acb38a9. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04472377-7acb38a9

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 110.9971wilson
Risk in group 210.9971wilson
Risk difference, group 1 minus group 20-0.003270.00327newcombe hybrid score
Risk ratio, group 1 over group 2111log
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treatfrom the risk difference intervalthe two groups' risks are equal

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Self-collected SpecimensThe beta-globin test results of the samples collected by the participants1,1701,170OG000
Group 2Physician-sampled SpecimensThe beta-globin test results of the samples collected by the physician1,1701,170OG001

Outcome

Type
SECONDARY
Title
Percentage of a Valid Specimen, According to the Presence of the Beta-globin Gene in Specimens
Description
Percentage of the presence of the beta-globin gene. The ratio could be calculated between self-collected and physician-collected specimens.
Time frame
14 days
Population

Source ClinicalTrials.gov

Trial

Title
HPV Typing Between Self- and Physician-sampled
NCT number
NCT04472377
Phases
NA
Conditions
Human Papillomavirus Infection, Self Sampling, Vaginal Discharge
Interventions
Self sampling kit for collecting discharge from vaginal fornix
Lead sponsor
Hygeia Touch Inc.
Results first posted
2024-08-12

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04472377-7acb38a9